名稱 | BCR-ABL1 E255K/BaF3 |
型號(hào) | CBP73318 |
報(bào)價(jià) | |
特點(diǎn) | BCR-ABL1 [E255K]/BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- TIGIT&PVRIG雙靶點(diǎn)細(xì)胞篩選模型
- 聚焦靶點(diǎn)BRAF——BRAF相關(guān)突變細(xì)胞強(qiáng)勢(shì)登場(chǎng)
- 細(xì)胞株的核型分析實(shí)驗(yàn)操作流程分析
- 5T4 (TPBG) 藥靶篩選模型
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 【靶點(diǎn)模型】AKT基因的藥物開發(fā)
- 科學(xué)家發(fā)現(xiàn)10個(gè)新的智力障礙易感基因
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73318BCR-ABL1 E255K/BaF3
- 詳細(xì)內(nèi)容
CBP73318 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [E255K]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [E255K]/BaF3 | |
2.Sanger of BCR-ABL1 [E255K]/BaF3 Figure 2. BCR-ABL1 [E255K]/BaF3 Figure 3. BCR-ABL1 [E255K]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 E255K Cells (C3). | |